• LGALS3BP 3959 Druggable Genome

    Alternate Names:

    3959
    GALECTIN 3 BINDING PROTEIN
    LGALS3BP
    90K
    BTBD17B
    CyCAP
    M2BP
    MAC-2-BP
    TANGO10B
    gp90
    600626
    6564
    ENSG00000108679
    OTTHUMG00000177572
    GALECTIN-3 BINDING PROTEIN PRECURSOR (LECTIN GALACTOSIDE-BINDING SOLUBLE 3 BINDING PROTEIN) (MAC-2 BINDING PROTEIN) (MAC-2 BP) (MAC2BP) (TUMOR-ASSOCIATED ANTIGEN 90K). [SOURCE:UNIPROT/SWISSPROT;ACC:Q08380]
    Q08380
    LG3BP_HUMAN
    GALECTIN-3-BINDING PROTEIN

    Gene Info:

    Human Readable Name DRUGGABLE GENOME
    Interpro Acc IPR001190
    Interpro Name Speract/scavenger receptor
    Uniprot Evidence 1: Evidence at protein level
    Uniprot Status Swiss-Prot
    Interpro Type Domain
    Interpro Short Name Srcr_rcpt
    Gene Biotype PROTEIN_CODING
    (0 More Sources)

    Gene Categories: Category Details

    DRUGGABLE GENOME

    Publications:

    • Version: 101_38

    Alternate Names:
    LGALS3BP Ensembl Gene Name

    Gene Info:
    Gene Biotype PROTEIN_CODING

    Publications:

    • Version: 26-July-2011

    Alternate Names:
    LGALS3BP Display Id
    GALECTIN-3 BINDING PROTEIN PRECURSOR (LECTIN GALACTOSIDE-BINDING SOLUBLE 3 BINDING PROTEIN) (MAC-2 BINDING PROTEIN) (MAC-2 BP) (MAC2BP) (TUMOR-ASSOCIATED ANTIGEN 90K). [SOURCE:UNIPROT/SWISSPROT;ACC:Q08380] Description
    ENSG00000108679 Ensembl Gene Id

    Gene Info:
    Human Readable Name DRUGGABLE GENOME

    Gene Categories:
    DRUGGABLE GENOME

    Publications:

    • Version: 11-September-2012

    Alternate Names:
    GALECTIN-3-BINDING PROTEIN Uniprot Protein Name
    3959 Entrez Gene Id
    LGALS3BP Uniprot Gene Name

    Gene Info:
    Interpro Name Speract/scavenger receptor
    Uniprot Evidence 1: Evidence at protein level
    Uniprot Status Swiss-Prot

    Gene Categories:
    DRUGGABLE GENOME

    Publications:

    • Version: 31-May-2017

    Alternate Names:
    ENSG00000108679 Gene Symbol
    LGALS3BP Ensembl Id

    Gene Info:

    Gene Categories:
    DRUGGABLE GENOME

    Publications: